# Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures

> **NCT03430206** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 78 (actual)

## Conditions studied

- Oxygen Deficiency
- Desaturation of Blood
- Hypoventilation
- Anesthesia; Adverse Effect

## Interventions

- **DEVICE:** High-flow nasal cannula

## Key facts

- **NCT ID:** NCT03430206
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-21
- **Primary completion:** 2018-10-02
- **Final completion:** 2018-10-02
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2020-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430206, "Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03430206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*